Karen Altobelli
Adult Health · Philadelphia, PANPI 1588604755
Payments from drug & device makers
Across 123 payments — averaging $22.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$802
- AbbVie$459
- Pfizer$261
- Exact Sciences$182
- Novo Nordisk$137
- Lilly USA, LLC$126
- plus $740 from 19 others
What the payments were for
- Food & beverage$2,708100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $802 |
| AbbVie | 29 | $459 |
| Pfizer | 14 | $261 |
| Exact Sciences | 9 | $182 |
| Novo Nordisk | 7 | $137 |
| Lilly USA, LLC | 6 | $126 |
| Merck | 6 | $99 |
| Amgen | 6 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
| Abbott | 1 | $70 |
| Dexcom, Inc. | 1 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Boston Scientific | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Lundbeck LLC | 1 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $23 |
| GSK | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Harmony Biosciences LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,708 in reported general payments places this provider in the 80th percentile of 899 adult health providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $34,651 |
| ProliaDenosumab | 16 | $27,619 |
| JanuviaSitagliptin Phosphate | 29 | $20,507 |
| JardianceEmpagliflozin | 15 | $19,166 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $15,156 |
| MounjaroTirzepatide | 11 | $11,175 |
| FarxigaDapagliflozin Propanediol | 12 | $7,873 |
| Risedronate Sodium | 27 | $4,131 |
| Atorvastatin Calcium | 238 | $3,722 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $3,632 |
| Losartan Potassium | 122 | $2,373 |
| Rosuvastatin Calcium | 85 | $2,023 |
| Metoprolol Succinate | 110 | $1,737 |
| Levothyroxine Sodium | 117 | $1,629 |
| Amlodipine Besylate | 184 | $1,555 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $261 | $34,65126 claims |
| AmgenProlia | $95 | $27,61916 claims |
| MerckJanuvia | $99 | $20,50729 claims |
| Boehringer IngelheimJardiance | $16 | $19,16615 claims |
| GSKTrelegy Ellipta | $20 | $15,15618 claims |
| Lilly USA, LLCMounjaro | $126 | $11,17511 claims |
| AstraZenecaFarxiga | $802 | $7,87312 claims |
| AbbVieSynthroid | $459 | $1,16125 claims |
| Almatica Pharma LLCSertraline Hcl | $23 | $29632 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 899 adult health providers in Pennsylvania.
Other adult health in Philadelphia
- Beth SandyPhiladelphia$924K
- Diane NewmanPhiladelphia$413K
- Abigail SmithPhiladelphia$302K
- Lauren MassimoPhiladelphia$139K
- Catherine HoldsworthPhiladelphia$64K
- Kevin CarneyPhiladelphia$53K
- Christine ChmielewskiPhiladelphia$52K
- Barbara RogersPhiladelphia$51K
- Joyce RossPhiladelphia$39K
- Veronica RichardsonPhiladelphia$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.